NOS2 and Parkinson disease: Interestingly, a nitric oxide synthase (NOS) inhibitor can suppress DRP1-mediated mitochondrial fragmentation in dopaminergic neurons, indicating that NO signaling is the linkage between MPP+ neurotoxicity and mitochondrial dynamics malfunction, which in part underlie the PD’s pathology [211].